Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...

It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for ...

Virginia Cancer Specialists announced today its participation as a leading clinical trial site in a landmark study evaluating daraxonrasib, a first‑in‑class targeted oral therapy for patients with ...

Pancreatic cancer is one of the most dire diagnoses in medicine. There are few available treatments, and they do little to ...

Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from ...

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to ...